Table of Contents
Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing global elderly population
3.2.1.2. Growing government initiatives and healthcare spending in healthcare technology
3.2.1.3. Shortage of skilled nurses and healthcare staff
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of mobile robot
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Healthcare Mobile Robots Market: Type Movement Analysis
4.2. Hospital Robots
4.2.1. Hospital Robots Market, 2018 – 2030 (USD Million)
4.3. Care Robots
4.3.1. Care Robots Market, 2018 – 2030 (USD Million)
4.4. Imaging Assistance
4.4.1. Imaging Assistance Market, 2018 – 2030 (USD Million)
4.5. Imaging Assistance
4.5.1. Imaging Assistance Market, 2018 – 2030 (USD Million)
4.6. Rehabilitation & Mobility Robots
4.6.1. Rehabilitation & Mobility Robots Market, 2018 – 2030 (USD Million)
4.7. Teleoperation & Telepresence Systems
4.7.1. Teleoperation & Telepresence Systems Market, 2018 – 2030 (USD Million)
4.8. Surgical Robot
4.8.1. Surgical Robots Systems Market, 2018 – 2030 (USD Million)
4.9. Walking Assisting Robot
4.9.1. Walking Assisting Robots Market, 2018 – 2030 (USD Million)
4.10. Others
4.10.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5. End-use Business Analysis
5.1. Healthcare Mobile Robots Market: End-use Movement Analysis
5.2. Hospitals
5.2.1. Hospitals Market, 2018 – 2030 (USD Million)
5.3. Ambulatory Surgical Centers
5.3.1. Ambulatory Surgical Centers Market, 2018 – 2030 (USD Million)
5.4. Rehabilitation Centers
5.4.1. Rehabilitation Centers Market, 2018 – 2030 (USD Million)
5.5. Research Institutes
5.5.1. Research Institutes Market, 2018 – 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Healthcare Mobile Robots Market Share By Region, 2022 & 2030
6.2. North America
6.2.1. SWOT Analysis
6.2.2. North America Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.2.3. U.S.
6.2.3.1. Key Country Dynamics
6.2.3.2. Target Disease Prevalence
6.2.3.3. Competitive Scenario
6.2.3.4. Regulatory Framework
6.2.3.5. U.S. Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.2.4. Canada
6.2.4.1. Key Country Dynamics
6.2.4.2. Target Disease Prevalence
6.2.4.3. Competitive Scenario
6.2.4.4. Regulatory Framework
6.2.4.5. Canada Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.3. Europe
6.3.1. Europe Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Target Disease Prevalence
6.3.2.3. Competitive Scenario
6.3.2.4. Regulatory Framework
6.3.2.5. UK Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Target Disease Prevalence
6.3.3.3. Competitive Scenario
6.3.3.4. Regulatory Framework
6.3.3.5. Germany Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Target Disease Prevalence
6.3.4.3. Competitive Scenario
6.3.4.4. Regulatory Framework
6.3.4.5. France Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Target Disease Prevalence
6.3.5.3. Competitive Scenario
6.3.5.4. Regulatory Framework
6.3.5.5. Italy Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Target Disease Prevalence
6.3.6.3. Competitive Scenario
6.3.6.4. Regulatory Framework
6.3.6.5. Spain Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Target Disease Prevalence
6.3.7.3. Competitive Scenario
6.3.7.4. Regulatory Framework
6.3.7.5. Denmark Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Target Disease Prevalence
6.3.8.3. Competitive Scenario
6.3.8.4. Regulatory Framework
6.3.8.5. Sweden Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Target Disease Prevalence
6.3.9.3. Competitive Scenario
6.3.9.4. Regulatory Framework
6.3.9.5. Norway Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Competitive Scenario
6.4.2.4. Regulatory Framework
6.4.2.5. Japan Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Competitive Scenario
6.4.3.4. Regulatory Framework
6.4.3.5. China Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Competitive Scenario
6.4.4.4. Regulatory Framework
6.4.4.5. India Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Target Disease Prevalence
6.4.5.3. Competitive Scenario
6.4.5.4. Regulatory Framework
6.4.5.5. Australia Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Target Disease Prevalence
6.4.6.3. Competitive Scenario
6.4.6.4. Regulatory Framework
6.4.6.5. Thailand Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. Target Disease Prevalence
6.4.7.3. Competitive Scenario
6.4.7.4. Regulatory Framework
6.4.7.5. South Korea Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Competitive Scenario
6.5.2.4. Regulatory Framework
6.5.2.5. Brazil Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Competitive Scenario
6.5.3.4. Regulatory Framework
6.5.3.5. Mexico Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Competitive Scenario
6.5.4.4. Regulatory Framework
6.5.4.5. Argentina Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.6. MEA
6.6.1. MEA Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Competitive Scenario
6.6.2.4. Regulatory Framework
6.6.2.5. South Africa Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Competitive Scenario
6.6.3.4. Regulatory Framework
6.6.3.5. Saudi Arabia Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Competitive Scenario
6.6.4.4. Regulatory Framework
6.6.4.5. UAE Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Competitive Scenario
6.6.5.4. Regulatory Framework
6.6.5.5. Kuwait Healthcare Mobile Robots Market, 2018 – 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Toyota Motor Corp.
7.1.1. Akebia Therapeutics, Inc.
7.1.1.1. Overview
7.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. ABB Ltd.
7.1.2.1. Overview
7.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Aethon
7.1.3.1. Overview
7.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Omron Corporation
7.1.4.1. Overview
7.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Amazon
7.1.5.1. Overview
7.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Mobile Industrial Robots
7.1.6.1. Overview
7.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Nordson Corp
7.1.7.1. Overview
7.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Teradyne
7.1.8.1. Overview
7.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Ateago Technology
7.1.9.1. Overview
7.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. VGo Communications, Inc.
7.1.10.1. Overview
7.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
7.1.11. Awabot
7.1.11.1. Overview
7.1.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.11.3. Product Benchmarking
7.1.11.4. Strategic Initiatives
7.1.12. Techcon
7.1.12.1. Overview
7.1.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.12.3. Product Benchmarking
7.1.12.4. Strategic Initiatives
7.1.13. Xenex Disinfection Services, LLC
7.1.13.1. Overview
7.1.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.13.3. Product Benchmarking
7.1.13.4. Strategic Initiatives
7.1.14. Intuition Robotics
7.1.14.1. Overview
7.1.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.14.3. Product Benchmarking
7.1.14.4. Strategic Initiatives
7.2. Participant’s Overview
7.3. Financial Performance
7.4. Product Benchmarking
7.5. Company Market Share Analysis, 2022
7.6. Strategy Mapping
7.6.1. Expansion
7.6.2. Acquisition
7.6.3. Product/Service Launch
7.6.4. Others
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer